Abionyx Pharma SA Cash Flow Quality Index

Latest as of June 2019: -1.02x

Abionyx Pharma SA cash flow quality index. Abionyx Pharma SA (ABNX) has a Cash Flow Quality Index of -1.02x as of June 2019. Operating cash flow of €-2.96 Million is below net income of €2.90 Million, suggesting accrual-heavy earnings not yet converted to cash. See Abionyx Pharma SA financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.02x
Operating CF / Net Income

Operating Cash Flow

€-2.96 Million
EUR

Net Income

€2.90 Million
EUR

Data as of

Jun 2019
Most recent filing

Cash Flow Quality Index of Abionyx Pharma SA (2019–2019)

Cash flow quality index of Abionyx Pharma SA from 2019 to 2019. Historical Cash Flow Quality Index for Abionyx Pharma SA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Abionyx Pharma SA (ABNX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Abionyx Pharma SA Cash Flow Quality Index by Year (2019–2019)

Abionyx Pharma SA cash flow quality index by year from 2019 to 2019. Year-by-year earnings quality comparison for Abionyx Pharma SA. For the full cash flow conversion analysis, see Abionyx Pharma SA cash conversion from operations.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2019 -2.14x €-3.95 Million €1.85 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.